Omega Fund Management, LLC
Omega Fund Management, LLC is a Boston-based venture capital firm founded in 2004 focused on supporting exceptional founders and entrepreneurs developing impactful products and platforms across multiple therapeutic areas. The firm specializes in life sciences and biotechnology investments, operates internationally, and employs approximately 23 professionals, serving institutional investors and emerging companies in the healthcare and biopharmaceutical sectors.
Investment Strategy
Omega Fund Management specializes in providing venture capital to companies in the life sciences and healthcare sectors, targeting opportunities with transformative potential in biotechnology and therapeutics. The firm partners with exceptional scientific founders and entrepreneurs, leveraging its deep industry experience, operational expertise, and global network to accelerate portfolio company growth. Omega emphasizes impactful innovation, cross-stage investments, and long-term partnerships to maximize value creation.
Top Holdings
Equity Positions (12)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
B BBNX | Beta Bionics Inc. | 18.75% | $28.9M | 1,988,287 | $12.24 | $14.56 | +$4.6M |
K KMTS | Kestra Med Technologies Ltd. | 17.67% | $27.3M | 1,645,893 | $24.92 | $16.58 | -$17.5M |
U UPB | Upstream Bio Inc. | 14.48% | $22.4M | 2,036,293 | $16.44 | $10.98 | +$9.9M |
N NUVB | Nuvation Bio | 13.94% | $21.5M | 11,042,728 | $10.45 | $1.95 | -$1.5M |
B BCAX | Bicara Therapeutics Inc. | 13.26% | $20.5M | 2,204,650 | $25.47 | $9.29 | -$8.2M |